-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Durham, North Carolina, USA and Beijing, September 28, 2021/PRNewswire/ - Brii Bioscience (stock code: 2137.
"As we rapidly advance the registration application of the BRII-196/BRII-198 combination therapy for the treatment of COVID-19 in the United States, in preparation for our next stage of development, Coy will become an indispensable part of our leadership team.
Prior to joining Tengsheng Biopharmaceuticals, Mr.
"Tengshengbo Pharmaceutical is in an exciting period of development.
For more information about Briibio and its leadership team, please visit the official website
About Tengshengbo Pharmaceutical
Tengsheng Bo Yao Biotechnology Co.